The Biotechnology Innovation Organization (BIO) is happy to announce the 50 finalists for the Start-Up Stadium at #BIO2018 June 4-7 in Boston. This is the fourth year for the program which is tailored to increasing engagement between investors and international/national/state/regional affiliates and early-stage companies at the beginning of their life-cycle within the burgeoning ecosystem in which they play. The 2018 finalists span 15 states and nine countries with focus areas that include therapeutics, diagnostics, digital/medical technology, and food & agriculture.
“Start-Up Stadium reaches into biotech ecosystems on a global scale,” said BIO President and CEO Jim Greenwood. “This includes some overlooked but promising regions for biotechnology start-ups that traditionally have limited access to investors. At BIO International Convention, entrepreneurs from all over the country and the world will get that critical exposure to investors, receive essential feedback on their businesses and make their pitch for capital. Participants will engage with judges representing all facets of the start-up supply chain – investors, lawyers, life science executives, university leaders, and policymakers.”
For the 2018 event, BIO created an online portal for early-stage companies to submit their pitch. Twenty-two first-round judges from the public and private sectors with collective expertise in early-stage investing, entrepreneurship, the start-up landscape, biotechnology, healthcare, and the life sciences made the initial selections. Forty-two finalist judges will provide live subject-matter feedback, with attention given to technologies that fill economic and consumer-based gaps in the biotechnology ecosystem.
Judges attend live presentations and engage in a Q&A, providing in-depth feedback to the finalists. Finalists participate in one of six sessions over four days. A six-minute pitch is followed by eight minutes of written and oral feedback from the judges. Through this competition, BIO is looking to provide resources that boost the biotechnology industry as well as provide a clear, successful example to stakeholders that early-stage innovation is well represented at the world’s largest biotechnology event.
In order to continually innovate and build upon the successes of previous years, as well as celebrate BIO’s 25th anniversary, this year we decided to kick it up a notch! Unlike previous years, finalist judges will be scoring each finalist presentation and selecting a winner from each session track for a total of six winners. Then, through the graciousness of our partners, the winners will be provided three prizes: 1) The BIO Prize—a one-year membership to BIO, 2) The Investor Prize—a one-hour advisory discussion with a venture capital firm (Sands Capital Ventures and F-Prime Capital Partners), and 3) The Innovation Prize—provided by MassChallenge, where the winners will be fast-tracked to the final judging round for the 2019 MassChallenge (industry agnostic accelerator) or PULSE@MassChallenge (digital health lab) programs.
BIO would like to thank our sponsors for the 2018 Start-Up Stadium event – VWR International, Mintz Levin Cohn Ferris Glovsky and Popeo PC, and MassChallenge – without whose help and support this event wouldn’t be possible.
View the list of 2018 Start-Up Stadium judges